PERCEPTIVE ADVISORS LLC Q1 2025 Filing
Filed May 15, 2025
Portfolio Value
$2.8T
Holdings
86
Report Date
Q1 2025
Filing Type
13F-HR
All Holdings (86 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | VRNAVERONA PHARMA PLC | 6,563,340 | $416.7B | 14.68% | |
| 2 | ACLXARCELLX INC | 2,926,478 | $192.0B | 6.76% | |
| 3 | AM6AMICUS THERAPEUTICS INC | 21,464,527 | $175.2B | 6.17% | |
| 4 | EWTXEDGEWISE THERAPEUTICS INC | 7,047,328 | $155.0B | 5.46% | Call |
| 5 | RYTMRHYTHM PHARMACEUTICALS INC | 2,548,445 | $135.0B | 4.76% | |
| 6 | NUVLNUVALENT INC | 1,633,968 | $115.9B | 4.08% | |
| 7 | SLNOSOLENO THERAPEUTICS INC | 1,506,602 | $107.6B | 3.79% | |
| 8 | ITCIEURINTRA-CELLULAR THERAPIES INC | 786,358 | $103.7B | 3.66% | |
| 9 | MGTXMEIRAGTX HLDGS PLC | 12,581,103 | $85.3B | 3.00% | |
| 10 | AORTARTIVION INC | 2,793,703 | $68.7B | 2.42% | |
| 11 | ALDXALDEYRA THERAPEUTICS INC | 9,275,851 | $53.3B | 1.88% | |
| 12 | PTGXPROTAGONIST THERAPEUTICS INC | 1,091,271 | $52.8B | 1.86% | |
| 13 | EOLSEVOLUS INC | 4,129,142 | $49.7B | 1.75% | |
| 14 | IMVTIMMUNOVANT INC | 2,844,072 | $48.6B | 1.71% | |
| 15 | SLDBSOLID BIOSCIENCES INC | 11,906,646 | $44.1B | 1.55% | |
| 16 | CNTACENTESSA PHARMACEUTICALS PLC | 3,040,395 | $43.7B | 1.54% | |
| 17 | IOVAIOVANCE BIOTHERAPEUTICS INC | 12,711,788 | $42.3B | 1.49% | |
| 18 | IMTXIMMATICS N.V | 9,383,456 | $42.3B | 1.49% | |
| 19 | APGEAPOGEE THERAPEUTICS INC | 1,122,767 | $41.9B | 1.48% | |
| 20 | AXSMAXSOME THERAPEUTICS INC | 355,107 | $41.4B | 1.46% | |
| 21 | IM8NINSMED INC | 509,300 | $38.9B | 1.37% | |
| 22 | SYRESPYRE THERAPEUTICS INC | 2,313,272 | $37.3B | 1.32% | |
| 23 | PRAXPRAXIS PRECISION MEDICINES I | 980,894 | $37.1B | 1.31% | |
| 24 | ARGXARGENX SE | 59,510 | $35.2B | 1.24% | |
| 25 | CATBUSDASTRIA THERAPEUTICS INC | 6,485,420 | $34.6B | 1.22% | |
| 26 | AKROAKERO THERAPEUTICS INC | 792,960 | $32.1B | 1.13% | |
| 27 | MRUSMERUS N V | 690,485 | $29.1B | 1.02% | |
| 28 | AMLXAMYLYX PHARMACEUTICALS INC | 7,874,348 | $27.9B | 0.98% | |
| 29 | ADMAADMA BIOLOGICS INC | 1,373,233 | $27.2B | 0.96% | |
| 30 | BBNXBETA BIONICS INC | 2,203,840 | $27.0B | 0.95% | |
| 31 | PCVXVAXCYTE INC | 706,567 | $26.7B | 0.94% | |
| 32 | JANXJANUX THERAPEUTICS INC | 970,412 | $26.2B | 0.92% | |
| 33 | DYNDYNE THERAPEUTICS INC | 2,313,403 | $24.2B | 0.85% | |
| 34 | CELCCELCUITY INC | 2,362,279 | $23.9B | 0.84% | |
| 35 | ZYMEZYMEWORKS INC | 1,864,672 | $22.2B | 0.78% | |
| 36 | ISRGINTUITIVE SURGICAL INC | 40,619 | $20.1B | 0.71% | |
| 37 | OBIOORCHESTRA BIOMED HLDGS INC | 4,592,556 | $19.7B | 0.69% | |
| 38 | PODDINSULET CORP | 71,597 | $18.8B | 0.66% | |
| 39 | RGENREPLIGEN CORP | 129,801 | $16.5B | 0.58% | |
| 40 | DRUGBRIGHT MINDS BIOSCIENCES INC | 444,649 | $16.0B | 0.57% | |
| 41 | MDGLMADRIGAL PHARMACEUTICALS INC | 46,500 | $15.4B | 0.54% | |
| 42 | INBXINHIBRX BIOSCIENCES INC | 1,064,026 | $14.9B | 0.52% | |
| 43 | BSXBOSTON SCIENTIFIC CORP | 130,000 | $13.1B | 0.46% | |
| 44 | SIONSIONNA THERAPEUTICS INC | 1,251,101 | $13.1B | 0.46% | |
| 45 | IKTINHIBIKASE THERAPEUTICS INC | 5,925,000 | $13.0B | 0.46% | |
| 46 | VKTXVIKING THERAPEUTICS INC | 509,005 | $12.3B | 0.43% | |
| 47 | DC4DEXCOM INC | 178,000 | $12.2B | 0.43% | |
| 48 | NBIXNEUROCRINE BIOSCIENCES | 100,050 | $11.1B | 0.39% | |
| 49 | XENEXENON PHARMACEUTICALS INC | 325,324 | $10.9B | 0.38% | |
| 50 | ACRVACRIVON THERAPEUTICS INC | 5,360,858 | $10.9B | 0.38% | |
| 51 | NAUTNAUTILUS BIOTECHNOLOGY INC | 12,594,211 | $10.8B | 0.38% | |
| 52 | AQSTAQUESTIVE THERAPEUTICS INC | 3,727,208 | $10.8B | 0.38% | |
| 53 | CTNMCONTINEUM THERAPEUTICS INC | 1,441,249 | $10.1B | 0.35% | |
| 54 | CRGXCARGO THERAPEUTICS INC | 2,431,085 | $9.9B | 0.35% | |
| 55 | OMOUTSET MED INC | 833,333 | $9.2B | 0.32% | |
| 56 | VRDNVIRIDIAN THERAPEUTICS INC | 659,662 | $8.9B | 0.31% | |
| 57 | EYPTEYEPOINT PHARMACEUTICALS INC | 1,537,274 | $8.3B | 0.29% | |
| 58 | ADGMADAGIO MED HLDGS INC | 9,812,419 | $7.9B | 0.28% | |
| 59 | AVRANTERIS TECHNOLOGIES GLOBAL | 2,140,000 | $7.8B | 0.27% | |
| 60 | IRONDISC MEDICINE INC | 150,000 | $7.4B | 0.26% | |
| 61 | ADPTADAPTIVE BIOTECHNOLOGIES COR | 930,972 | $6.9B | 0.24% | |
| 62 | OCULOCULAR THERAPEUTIX INC | 915,775 | $6.7B | 0.24% | |
| 63 | DCTHDELCATH SYS INC | 462,422 | $5.9B | 0.21% | |
| 64 | RAPTEURRAPT THERAPEUTICS INC | 4,418,947 | $5.4B | 0.19% | |
| 65 | KMTSKESTRA MED TECHNOLOGIES LTD | 200,000 | $5.0B | 0.18% | |
| 66 | HLXCHELIX ACQUISITION CORP II | 398,000 | $4.5B | 0.16% | |
| 67 | OKURONKURE THERAPEUTICS INC | 1,004,439 | $4.3B | 0.15% | |
| 68 | IRDOPUS GENETICS INC | 4,325,000 | $4.2B | 0.15% | |
| 69 | AVTXAVALO THERAPEUTICS INC | 520,000 | $4.2B | 0.15% | |
| 70 | NRIXNURIX THERAPEUTICS INC | 297,553 | $3.5B | 0.12% | |
| 71 | MREOMEREO BIOPHARMA GROUP PLC | 876,961 | $2.0B | 0.07% | |
| 72 | LYRALYRA THERAPEUTICS INC | 12,757,562 | $1.6B | 0.06% | |
| 73 | KALAKALA BIO INC | 277,610 | $1.6B | 0.06% | |
| 74 | —ATHIRA PHARMA INC | 5,402,964 | $1.5B | 0.05% | |
| 75 | BDSXBIODESIX INC | 2,173,880 | $1.4B | 0.05% | |
| 76 | SCPHSCPHARMACEUTICALS INC | 500,000 | $1.3B | 0.05% | |
| 77 | TRAWTRAWS PHARMA INC | 421,781 | $970.1M | 0.03% | |
| 78 | RCKTROCKET PHARMACEUTICALS INC | 140,726 | $938.6M | 0.03% | |
| 79 | CGEMCULLINAN THERAPEUTICS INC | 80,100 | $606.4M | 0.02% | |
| 80 | LXEOLEXEO THERAPEUTICS INC | 139,835 | $485.2M | 0.02% | |
| 81 | APLTAPPLIED THERAPEUTICS INC | 860,000 | $420.5M | 0.01% | |
| 82 | NBTXNANOBIOTIX | 105,053 | $376.1M | 0.01% | |
| 83 | ENSCENSYSCE BIOSCIENCES INC | 86,666 | $221.9M | 0.01% | |
| 84 | APYXAPYX MEDICAL CORPORATION | 150,000 | $205.5M | 0.01% | |
| 85 | RVMDWREVOLUTION MEDICINES INC | 250,000 | $9.5M | 0.00% | |
| 86 | SRZNWSURROZEN INC | 166,666 | $5.0M | 0.00% |